Yoram Shechter

Rehovot, M 76100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells.

Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells.

Journal: Pharmaceutics

Published: November 30, 2021

Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.

Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.

Journal: Pharmaceutics

Published: July 04, 2021

Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.

Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.

Journal: Toxicology and applied pharmacology

Published: July 14, 2019

Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations.

Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations.

Journal: PloS one

Published: April 11, 2016

Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.

Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: July 30, 2014

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.

Journal: Diabetes

Published: December 20, 2012

Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.

Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.

Journal: The Journal of biological chemistry

Published: November 15, 2012

Establishing the principle of reversibility in peptide/protein and small-molecule therapy.

Establishing the principle of reversibility in peptide/protein and small-molecule therapy.

Journal: Therapeutic delivery

Published: July 27, 2012

Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin.

Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin.

Journal: Bioconjugate chemistry

Published: July 05, 2012

Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 07, 2001

Showing 1-10 of 10

Last Updated: 09/26/2026